Geron Loan Draws Media Attention to CIRM
The state of California's first-ever venture into a clinical trial involving human embryonic stem cells garnered more than the usual news coverage last week for the Golden State's $3 billion stem cell research effort.
At least more than usual for the stem cell agency, which has received modest attention in the mainstream media in recent years.
The $25 mil…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.